LHX2 and breast cancer: Kuzmanov et al. reported the increased expression of LHX2 in TGF-β-induced EMT processes in breast cancer [9], whilst others demonstrated that LHX2 activates Wnt/β-catenin signaling to promote EMT in pancreatic ductal carcinoma nasopharyngeal carcinoma [8].